Articles
| Open Access |
https://doi.org/10.55640/
COVID-19 INFECTION AND NEUROLOGICAL COMPLICATIONS.
Bahromov Asliddin Bahodir ugli , Termez University of Economics and Service. Termez city. Alimova Zebiniso Farkhodjon kizi , Lecturer at the Department of Fundamental Medical Sciences, Termez University of Economics and Service. Termez city.Abstract
This article discusses the COVID-19 infection caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the etiological agent of COVID-19 disease, which has caused a pandemic, severely affecting not only the lungs but also the central and peripheral nervous systems.
Keywords
Sars-CoV-2, Hemorrhagic stroke, Cerebrovascular thrombosis, Encephalitis, Guillain-Barre syndrome, Hematogenous pathway, Transcriptional pathway, Enteric nervous system, Cognitive.
References
Mao L, Jin H. Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA 2020:77(6):683-690. Neurol.
Ellul MA, Benjamin L, Singh B, et al. Neurological associations of 2020;19(9):767-783. COVID-19. Lancet Neurol.
World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Accessed November 1, 2025.
Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21(3):133-146.
Ceban F. Ling S, Lui LMW, et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis. Brain Behav Immun. 2022:101:93-135.
Taquet M, Sillett R, Zhu L, et al. Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an. analysis of 2-year retrospective cohort studies including 1 284 437 patients. Lancet Psychiatry. 2022:9(10):815-827.
Premraj L. Kannapadi NV, Briggs J, et al. Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis. J Neurol Sci. 2022;434:120162.
Ntaios G. Michel P. Georgiopoulos G, et al. Characteristics and outcomes in patients with COVID-19 and stroke: a meta-analysis. Stroke. 2022:53(5):1501-1510.
Sheikh AB, Javed N. Sheikh AAE, et al. Guillain-Barré syndrome and COVID-19: A systematic review and meta-analysis. Neurol Sci. 2022;43(5):2887-2896.
Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond). 2021;53(10):737-754.
Song E, Zhang C, Israelow B, et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J Exp Med. 2021;218(3):e20202135.
Matschke J, Sperhake JP, Lütgehetmann M, et al.
Neuropathology of patients with COVID-19 in Germany: a post-mortem. case Neurol. 2020:19(11):919-929. series. Lancet
Douaud M, Lee S, Alfaro-Almagro F, et al. SARS-CoV-2 is associated with changes in brain structure in UK Biobank. Nature. 2022;604(7907):697-707.
Monje M. Iwasaki A. The neurobiology of Long COVID. Neuron. 2022;110(21):3484-3496.
Frontera JA, Boutajangout A, Masur J, et al. Neurological events and neurofilament light chain in COVID -19: a 12-month prospective study. Ann Neurol. 2024:95(3):456-469.
Article Statistics
Downloads
Copyright License
This work is licensed under a Creative Commons Attribution 4.0 International License.